$CNTB Income Statement | Understand Stock

$CNTB

$0.85 +$0.00 (0.33%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Research and development expenses
Administrative expenses
Net impairment losses
Other income
Other (losses)/gains—net
Operating loss
Finance income
Finance cost
Finance income—net
Fair value loss of financial instruments with preferred rights
Loss before income tax
Basic and diluted
Basic (in dollars per share)
License and collaboration revenues
Operating expenses:
Research and development expense
General and administrative expense
Total operating expenses
Loss from operations
Other income, net:
Interest income
Other income (expense)
Total other income, net
Net loss before income tax
Income tax expense
Net loss
Other comprehensive loss:
Foreign currency translation adjustments
Unrealized gains (losses) on available-for-sale investments
Comprehensive loss
Basic net loss per ordinary share (in dollars per share)
Diluted net loss per ordinary share (in dollars per share)
Weighted-average ordinary shares outstanding, basic (in shares)
Weighted-average ordinary shares outstanding, diluted (in shares)

Comments